Nordson/$NDSN

1D1W1MYTD1Y5YMAX

About Nordson

Nordson manufactures equipment (including pumps, valves, dispensers, applicators, filters, and pelletizers) used for dispensing adhesives, coatings, sealants, and other materials. The firm serves a diverse range of end markets, including packaging, medical, electronics, and industrial. Nordson's business is organized into three segments: industrial precision solutions, medical and fluid solutions, and advanced technology solutions. The company generated approximately $2.8 billion in revenue in its fiscal 2025.
Ticker
$NDSN
Primary listing
NASDAQ
Employees
8,200

Nordson Metrics

BasicAdvanced
$18B
32.33
$9.89
0.96
$3.28
1.03%

What the Analysts think about Nordson

Analyst ratings (Buy, Hold, Sell) for Nordson stock.
Analyst projections of the future price of Nordson stock.

Bulls say / Bears say

Nordson delivered record third-quarter sales of $818 million, up 10%, with organic growth across all three segments. Backlog was up 35% year on year, prompting the company to raise its full-year sales and adjusted earnings guidance. (Business Wire, Nordson)
The Advanced Technology Solutions segment is benefiting from strong semiconductor and electronics demand: third-quarter organic sales rose 31% and segment EBITDA rose 58%. Medical and Fluid Solutions also delivered record sales and 11% organic growth excluding the divested contract-manufacturing business. (Nordson, Longbridge)
Nordson is becoming less dependent on slower industrial markets, with more than half of its portfolio in growth end markets and about 60% generating recurring revenue from parts, consumables and services. Strong cash generation is allowing it to reduce debt, return capital to shareholders and continue investing for growth. (Exa, Nordson)
Advanced Technology Solutions appears to be at a cyclical peak. Management expects growth to return to a longer-term mid-single-digit rate, so the current surge in semiconductor and electronics demand may not be a reliable base for future earnings. (Longbridge, Exa)
Industrial Precision Solutions remains comparatively weak: third-quarter organic sales grew only 3%, while broader industrial and agricultural systems demand was described as stable but with limited growth. Its EBITDA margin was 35%, below 37% a year earlier. (Longbridge, TradingKey)
Portfolio reshaping makes the headline growth less clean: the medical contract-manufacturing divestiture reduced reported medical growth, while acquisitions and divestitures reduced consolidated growth. Nordson also warns that tariffs, geopolitical conditions and currency movements could hurt cash flow, while its raised outlook depends on strong fourth-quarter momentum and stable exchange rates. (Nordson, Business Wire)
Data summarised monthly by Lightyear AI. Last updated on 17 Sept 2026.

Nordson Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Nordson Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Funds containing Nordson

AllUSDEURGBP
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.